Insider · CIK 0001493714
Ashleigh Palmer
Files at PRVB (Provention Bio, Inc.). First filing Jan 20, 2023, latest Feb 14, 2023.
In brief
Ashleigh Palmer files SEC Form 4 as CEO and director at PRVB (Provention Bio, Inc.). Since Jan 20, 2023, Ashleigh Palmer has reported 0 open-market buys worth $0 and 2 open-market sells worth $1.0M, the latest filed on Feb 14, 2023.
A track record needs three past buys with six months of prices behind them; Ashleigh Palmer has 0, so none is measured yet.
The newest scored trade: sold $765k of PRVB on Feb 10, 2023, filed Feb 14, 2023, scored 27 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | Provention Bio, Inc. | $765k 75,835 shares | -3% | - | |
| 18Weak | Provention Bio, Inc. | $248k 24,165 shares | -1% | - |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2023 | PRVB Provention Bio, Inc. | UTender of shares Common Stock | -2,570,050 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -441,720 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -400,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -137,750 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -139,500 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -360,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -700,000 | - | - | 0 | Apr 27, 2023 |
| Feb 10, 2023 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +50,000 | $2.50 | $125k | 2,620,050 | Feb 14, 2023 |
| Feb 10, 2023 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -50,000 | $10.11 | $506k | 2,570,050 | Feb 14, 2023 |
| Feb 13, 2023 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +25,835 | $2.50 | $65k | 2,595,885 | Feb 14, 2023 |
| Feb 13, 2023 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -25,835 | $10.04 | $259k | 2,570,050 | Feb 14, 2023 |
| Feb 10, 2023 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 467,555 | Feb 14, 2023 |
| Feb 13, 2023 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -25,835 | $0.00 | $0 | 441,720 | Feb 14, 2023 |
| Jan 18, 2023 | PRVB Provention Bio, Inc. | MOption exercise Common Stock | +24,165 | $2.50 | $60k | 2,594,215 | Jan 20, 2023 |
| Jan 18, 2023 | PRVB Provention Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -24,165 | $10.27 | $248k | 2,570,050 | Jan 20, 2023 |
| Jan 18, 2023 | PRVB Provention Bio, Inc. | MOption exercise Stock Option (right to buy)derivative | -24,165 | $0.00 | $0 | 517,555 | Jan 20, 2023 |
| Jan 17, 2023 | PRVB Provention Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +700,000 | $0.00 | $0 | 700,000 | Jan 18, 2023 |
| Dec 8, 2022 | PRVB Provention Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,663 | $0.00 | $0 | 75,763 | Dec 9, 2022 |
| Nov 22, 2022 | PRVB Provention Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 400,000 | Nov 23, 2022 |
Questions about Ashleigh Palmer
Answered from the filings on this page, as of the latest one.
Is Ashleigh Palmer buying or selling?
Not in the last 12 months. Ashleigh Palmer's latest open-market trade on SEC Form 4 was sold $765k of PRVB on Feb 10, 2023.
How did Ashleigh Palmer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ashleigh Palmer has 0.
Where does Ashleigh Palmer file Form 4?
Ashleigh Palmer has filed Form 4 at PRVB (Provention Bio, Inc.) as Director and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.